Alan P. Lyss, MD

All articles by Alan P. Lyss, MD

Alan P. Lyss, MD

May 26, 2023

Changes to primary endpoints of phase 3 cancer trials may be common and underreported, a study suggests.

Alan P. Lyss, MD

December 22, 2022

At a SITC summit, stakeholders identified administrative, staffing, and other barriers that impede progress in clinical cancer research.

Alan P. Lyss, MD

September 23, 2022

New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.

Alan P. Lyss, MD

March 30, 2022

New research suggests aspirin may lower the risk for gastric adenocarcinoma in women but not in men.

Next post in General Hematology